Sintx Technologies (SINT) EBITDA Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Sintx Technologies (SINT) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 244.00 |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -18,402.00 |
| Dec 31, 2025 | -42,271.00 |
| Sep 30, 2025 | -95,735.00 |
| Jun 30, 2025 | -60,532.00 |
| Mar 31, 2025 | 158,676.00 |
| Dec 31, 2024 | 125,075.00 |
| Sep 30, 2024 | 38,001.00 |
| Jun 30, 2024 | 202,412.00 |
| Mar 31, 2024 | 234,751.00 |
| Dec 31, 2023 | 162,743.00 |
| Sep 30, 2023 | 314,575.00 |
| Jun 30, 2023 | 29,066.00 |
| Mar 31, 2023 | 23,573.00 |
| Dec 31, 2022 | 27,459.00 |
| Sep 30, 2022 | 32,703.00 |
| Jun 30, 2022 | -24,821.00 |
| Mar 31, 2022 | -44,905.00 |
| Jun 30, 2021 | -224,632.00 |
| Mar 31, 2021 | -271,549.00 |
| Dec 31, 2020 | -185,063.00 |